Significant Ownership of Prosight Management, LP
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Prosight Management, LP focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- Prosight Partners, LLC - General Partner
- Manager location
- Dallas, TX
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Prosight Management, LP and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
CIK context first
Continue from Prosight Management, LP
Significant Ownership of Prosight Management, LP
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| STTK | Shattuck Labs, Inc. | Common Stock, $0.0001 par value per share | 9.9% | $15,638,344 | 6,543,240 | Prosight Management, LP | 30 Sep 2025 | ||
| ADCT | ADC THERAPEUTICS SA | Common Shares | 6.8% | $31,366,151 | +$4,743,267 | 8,477,338 | +18% | Prosight Management, LP | 31 Dec 2025 |
| OKUR | OnKure Therapeutics, Inc. | Class A Common Stock, par value $0.0001 per share | 5.8% | $2,214,578 | 745,649 | Prosight Management, LP | 24 Nov 2025 | ||
| JANX | Janux Therapeutics, Inc. | Common Stock, $0.001 par value per share | 5.3% | $43,569,636 | 3,157,220 | W. Lawrence Hawkins | 03 Feb 2026 | ||
| VINC | Vincerx Pharma, Inc. | Common Stock, $0.0001 par value per share | 5% | $7,823 | 111,755 | Prosight Management, LP | 31 Dec 2024 | ||
| MGTX | MeiraGTx Holdings plc | Ordinary Shares, $0.00003881 par value per share | 4% | $23,702,995 | -$8,448,499 | 3,211,788 | -26% | W. Lawrence Hawkins | 31 Dec 2025 |
| MURA | Mural Oncology plc | Ordinary Shares, nominal value $0.01 per share | 0% | $0 | -$1,862,820 | 0 | -100% | Prosight Management, LP | 30 Sep 2025 |
Schedules 13D/G Reported by Prosight Management, LP:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.